Gemmer Asset Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-263
Closed -$21K 1279
2016
Q4
$21K Hold
263
0.01% 323
2016
Q3
$21K Hold
263
0.01% 324
2016
Q2
$21K Sell
263
-440
-63% -$31.4K 0.01% 300
2016
Q1
$38K Buy
703
+2
+0.3% +$109 0.02% 195
2015
Q4
$43K Sell
701
-498
-42% -$31.4K 0.03% 176
2015
Q3
$76K Buy
1,199
+501
+72% +$35.8K 0.05% 120
2015
Q2
$51K Buy
698
+2
+0.3% +$144 0.03% 178
2015
Q1
$45K Buy
696
+2
+0.3% +$133 0.03% 188
2014
Q4
$45K Buy
694
+2
+0.3% +$129 0.03% 185
2014
Q3
$42K Buy
692
+2
+0.3% +$131 0.03% 189
2014
Q2
$48K Buy
690
+2
+0.3% +$130 0.03% 174
2014
Q1
$45K Buy
+688
New +$44.8K 0.03% 181

Other funds holding STJ

Gemmer Asset Management's STJ Position: Q1 2017 in Review

Gemmer Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 263 shares — an estimated $21K sold.

Gemmer Asset Management first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $76K in Q3 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Gemmer Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Gemmer Asset Management sold 263 St Jude Medical shares in Q1 2017, an estimated $21K.
  • Gemmer Asset Management first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
  • Gemmer Asset Management's St Jude Medical position peaked at $76K in Q3 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Gemmer Asset Management's 13F filing for Q1 2017, filed 20 Apr 2017.